United States · Bill · HR
H.R. 5568 (115th)
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Introduced
18 April 2018
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018 This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 18 April 2018
Introduced in House (PDF)
Introduced in House · EN · 18 April 2018
Introduced in House
summary · EN · 18 April 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/5568
- Open data entity: https://api.congress.gov/v3/bill/115/hr/5568